These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 3012397

  • 1. Interaction between [3H]ethylketocyclazocine and [3H]etorphine and opioid receptors in membranes from rat brain. A kinetic analysis.
    Fischel SV, Medzihradsky F.
    Neuropharmacology; 1986 Apr; 25(4):351-9. PubMed ID: 3012397
    [Abstract] [Full Text] [Related]

  • 2. Resolution in the receptor binding of putative mu and kappa opiates.
    Medzihradsky F, Dahlstrom PJ, Woods JH, Fischel SV, Mitsos SE.
    Life Sci; 1984 May 28; 34(22):2129-38. PubMed ID: 6145076
    [Abstract] [Full Text] [Related]

  • 3. Heterogeneity of opioid receptor binding in brain slices.
    Barchfeld-Rothschild CC, Medzihradsky F.
    J Neurosci Res; 1987 May 28; 18(2):358-65. PubMed ID: 2891857
    [Abstract] [Full Text] [Related]

  • 4. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS, Dufau ML, Catt KJ.
    Endocrinology; 1987 Jul 28; 121(1):384-94. PubMed ID: 3036471
    [Abstract] [Full Text] [Related]

  • 5. Opioid receptors of bovine posterior pituitary neurosecretosomes are exclusively kappa.
    Pesce GO, Lang MA, Cruciani RA, Russell JT, Gainer H, Rodbard D.
    NIDA Res Monogr; 1986 Jul 28; 75():77-80. PubMed ID: 2893283
    [Abstract] [Full Text] [Related]

  • 6. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC, Kouakou Y, Puget A, Moisand C.
    Mol Pharmacol; 1983 Jul 28; 24(1):23-9. PubMed ID: 6306437
    [Abstract] [Full Text] [Related]

  • 7. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites.
    Castanas E, Bourhim N, Giraud P, Boudouresque F, Cantau P, Oliver C.
    J Neurochem; 1985 Sep 28; 45(3):688-99. PubMed ID: 2993510
    [Abstract] [Full Text] [Related]

  • 8. (+)-[3H]SKF 10,047, (+)-[3H]ethylketocyclazocine, mu, kappa, delta and phencyclidine binding sites in guinea pig brain membranes.
    Tam SW.
    Eur J Pharmacol; 1985 Feb 12; 109(1):33-41. PubMed ID: 2986989
    [Abstract] [Full Text] [Related]

  • 9. Benzomorphan binding sites in rat lumbo-sacral spinal cord.
    Gouardéres C, Audigier Y, Cros J.
    Eur J Pharmacol; 1982 Mar 26; 78(4):483-6. PubMed ID: 6281039
    [Abstract] [Full Text] [Related]

  • 10. Binding characteristics of kappa opioids in rat brain. A comparison of in vitro binding paradigms.
    Weyhenmeyer JA, Mack KJ.
    Neuropharmacology; 1985 Feb 26; 24(2):111-5. PubMed ID: 2986030
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological characterization of the binding of [3H]bremazocine in guinea-pig brain: evidence for multiplicity of the kappa-opioid receptors.
    Tiberi M, Magnan J.
    Can J Physiol Pharmacol; 1989 Oct 26; 67(10):1336-44. PubMed ID: 2558788
    [Abstract] [Full Text] [Related]

  • 12. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
    Castanas E, Giraud P, Audigier Y, Drissi R, Boudouresque F, Conte-Devolx B, Oliver C.
    Mol Pharmacol; 1984 Jan 26; 25(1):38-45. PubMed ID: 6323951
    [Abstract] [Full Text] [Related]

  • 13. Differences of binding characteristics of non-selective opiates towards mu and delta receptor types.
    Delay-Goyet P, Roques BP, Zajac JM.
    Life Sci; 1987 Aug 10; 41(6):723-31. PubMed ID: 3039270
    [Abstract] [Full Text] [Related]

  • 14. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
    James IF, Bettaney J, Perkins MN, Ketchum SB, Dray A.
    Br J Pharmacol; 1990 Mar 10; 99(3):503-8. PubMed ID: 2158845
    [Abstract] [Full Text] [Related]

  • 15. Further demonstration of kappa opioid binding sites in the brain: evidence for heterogeneity.
    Su TP.
    J Pharmacol Exp Ther; 1985 Jan 10; 232(1):144-8. PubMed ID: 2856939
    [Abstract] [Full Text] [Related]

  • 16. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB, Schmidt WK, Kuhar MJ.
    J Pharmacol Exp Ther; 1988 Jan 10; 244(1):391-402. PubMed ID: 2826773
    [Abstract] [Full Text] [Related]

  • 17. Computer modeling of subtypes of kappa opioid receptors in adrenal medulla.
    Pesce GO, Cruciani RA, Munson PJ, Rodbard D.
    Eur J Pharmacol; 1990 Jul 17; 182(3):429-39. PubMed ID: 2171945
    [Abstract] [Full Text] [Related]

  • 18. [3H]U-69593 labels a subtype of kappa opiate receptor with characteristics different from that labeled by [3H]ethylketocyclazocine.
    Nock B, Rajpara A, O'Connor LH, Cicero TJ.
    Life Sci; 1988 Jul 17; 42(23):2403-12. PubMed ID: 2836684
    [Abstract] [Full Text] [Related]

  • 19. Effects of guanyl nucleotides and ions on kappa opioid binding.
    Mack KJ, Lee MF, Weyhenmeyer JA.
    Brain Res Bull; 1985 Apr 17; 14(4):301-6. PubMed ID: 2988712
    [Abstract] [Full Text] [Related]

  • 20. Evidence for multiple "Kappa" binding sites by use of opioid peptides in the guinea-pig lumbo-sacral spinal cord.
    Attali B, Gouardères C, Mazarguil H, Audigier Y, Cros J.
    Neuropeptides; 1982 Oct 17; 3(1):53-64. PubMed ID: 6296719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.